
Treatment outcome of different antiretroviral drug regimens in HIV-positive pregnant women
Author(s) -
Nidhi Chauhan,
Mira Desai,
Samidh Shah,
Asha Shah,
Rajendra Gadhavi
Publication year - 2021
Publication title -
perspectives in clinical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.649
H-Index - 8
eISSN - 2229-5488
pISSN - 2229-3485
DOI - 10.4103/picr.picr_74_19
Subject(s) - medicine , pregnancy , regimen , zidovudine , apgar score , birth weight , gestational age , obstetrics , fetus , gestation , pediatrics , human immunodeficiency virus (hiv) , immunology , viral disease , genetics , biology
The objective of the study was to compare the maternal and fetal outcomes of currently preferred tenofovir-based regimen with previous zidovudine-based regimen and also to determine whether the time of starting antiretroviral therapy (ART), whether it can affect the pregnancy and fetal outcome.